Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome analysis of MAZR and/or Runx3-deficient cytotoxic T lymphocytes

ABSTRACT: Transcriptome analysis of MAZR and/or Runx3-deficient cytotoxic T lymphocytes

PROVIDER: PRJNA532724 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Transcriptome analysis of MAZR and/or Runx3-deficient cytotoxic T lymphocytes

Project description:We investigated transcriptional changes in MAZR-, Runx3- and MAZR/Runx3-deficient cytotoxic T lymphocytes (CTLs). This analysis revealed that MAZR plays a compensatory role in the Runx3-dependent transcriptional program of CTL differentiation.

2021-03-11 | GSE129772 | GEO

Runx3-mediated transcriptional program in cytotoxic lymphocytes.

Project description: Not available

| S-EPMC3827420 | biostudies-literature

Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis

Project description:Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis

| PRJNA417187 | ENA

In-depth analysis of the phosphoprotein landscape of cytotoxic T lymphocytes and its regulation by cytokines

Project description:Here we present high-resolution mass spectrometry analysis of changes to the phosphoproteome of cytotoxic T lymphocytes (CTL) induced by the cytokine, Interleukin 12 (IL-12). We treated CTL with a short and long IL-12 stimulation and mapped the changes to the phosphoproteome using quantitative SILAC-based phosphoproteomics.

2016-08-24 | PXD004644 | Pride

Personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against metastatic ovarian cancer

Project description:Neoantigen-reactive cytotoxic T lymphocytes play a vital role in precise cancer cell elimination. In this study, we demonstrate the effectiveness of personalized neoantigen-based T cell therapy in inducing tumor regression in two patients suffering from heavily-burdened metastatic ovarian cancer. Our approach involved the development of a robust pipeline for ex vivo expansion of neoantigen-reactive T lymphocytes. Neoantigen peptides were designed and synthesized based on the somatic mutations of the tumors and their predicted HLA binding affinities. These peptides were then presented to T lymphocytes through co-culture with neoantigen-loaded dendritic cells for ex vivo expansion. Subsequent to cell therapy, both patients exhibited significant reductions in tumor marker levels and experienced substantial tumor regression. One patient achieved repeated cancer regression through infusions of T cell products generated from newly identified neoantigens. Transcriptomic analyses revealed a remarkable increase in neoantigen-reactive cytotoxic lymphocytes in the peripheral blood of the patients following cell therapy. These cytotoxic T lymphocytes expressed polyclonal T cell receptors (TCR) against neoantigens, along with abundant cytotoxic proteins and pro-inflammatory cytokines. The efficacy of neoantigen targeting was significantly associated with the immunogenicity and TCR polyclonality. Notably, the neoantigen-specific TCR clonotypes persisted in the peripheral blood after cell therapy. Our findings indicate that personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against ovarian cancer, suggesting its promising potential in cancer immunotherapy.

2023-12-01 | GSE248401 | GEO

Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis [TCRseq]

Project description:Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis [TCRseq]

| PRJNA417192 | ENA

Actinomycin D treated cytotoxic T lymphocytes

Project description:Effector cytotoxic T lymphocytes (CTLs) are critical for ridding the body of infected or cancerous cells. Recognition of an antigenic ligand by the CTL’s T cell receptor (TCR) triggers a signalling cascade that ultimately results in the targeted release of cytolytic granules and/or secretion of cytokines and chemokines to alert and recruit additional immune cells. These signalling cascades are capable of initiating transcription, translation, and cytoskeletal rearrangements. While previous work has demonstrated how translation and intracellular reorganisation contribute to CTL effector responses, the role of transcription is less well studied. To address this, we examined the impact of blocking transcription on the CTL proteome during TCR stimulation. These data demonstrated a strong transcriptional requirement for expression of cytokines and chemokines but not cytolytic molecules. Together with functional studies, these data reveal differential molecular control of the cell-cell communication and cytolytic functions of effector CTLs. CTLs exhibit complete and persistent priming for cytolytic activity prior to target cell encounter, but they require de novo transcription to recruit additional immune cells that amplify the response.

2023-10-16 | PXD034920 | Pride

Cytotoxic lymphocytes use mechanosurveillance to target biophysical vulnerabilities in cancer

Project description:Cytotoxic lymphocytes use mechanosurveillance to target biophysical vulnerabilities in cancer

| PRJNA692218 | ENA

RNA-seq of human CD8low and CD8high cytotoxic T lymphocytes upon in vitro starvation

Project description:The mechanistic target of rapamycin (mTOR) signaling, which is an essential metabolic pathway that influences T cell differentiation, can be limited under conditions of metabolic stress e.g. during the cell starvation. As we observed reduced CD8 expression upon cell starvation in vitro, we sorted human cytotoxic T lymphocytes derived from six donors into low CD8 expression and high CD8 expressing T lymphocytes using flow cytometry. Their transcriptome was analyzed in order to investigate the two CD8 subsets. Our data suggests a functional diversity of CD8low and CD8high T cells with regard to cytotoxic effector function that might be useful to study these cells also in tumor sections or under conditions when cytotoxic T cells need to adapt to a changing microenvironment.

2022-09-30 | GSE207621 | GEO

Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis [10X genomics]

Project description:Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis [10X genomics]

| PRJNA417193 | ENA